- Record: found
- Abstract: not found
- Article: not found
A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial
A. Jatoi ,
P.D. Steen ,
P.J. Atherton ,
D.F. Moore ,
K.M. Rowland ,
N.A. Le-Lindqwister ,
C.S. Adonizio ,
A.J. Jaslowski ,
J. Sloan ,
C. Loprinzi
August 2017
August 2017
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Multiple pilot studies, including one in colorectal cancer patients, suggest that
creatine, an amino acid derivative, augments muscle, improves strength, and thereby
could palliate the cancer anorexia/weight loss syndrome.